Updated
Updated · Bloomberg · May 8Isomorphic Labs nears more than $2 billion funding round
10 articles · Updated · Bloomberg · May 8
- Thrive Capital is set to lead the financing, with Alphabet also participating, though the round has not yet closed.
- The company is an AI-powered drug discovery group spun out of Alphabet's Google DeepMind and is in advanced discussions on the raise.
- Thrive Capital also led Isomorphic Labs' first funding round last year, underscoring continued investor interest in AI-driven drug development.
Is Isomorphic Labs' $2 billion funding a landmark for AI medicine or a bubble set to pop before clinical proof? Its AI reportedly doubles AlphaFold's power, but with results secret, can it actually deliver cures for patients?